Peramivir
Back to searchMolecule Structure
Scientific Name
Peramivir
Description of the Drug
Peramivir is an intravenous antiviral agent used to treat acute uncomplicated influenza in patients aged 2 years and older who are shown to be symptomatic for no more than two days.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06614
http://www.drugbank.ca/drugs/DB06614
Brand Name(s)
Not Available
Company Owner(s)
Biocryst Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Neuraminidase | SINGLE PROTEIN | INHIBITOR | CHEMBL2051 |
| Neuraminidase | SINGLE PROTEIN | INHIBITOR | CHEMBL3377 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL744373 | ||
| DrugBank | DB06614 | ||
| PubChem: Thomson Pharma | 14850922 | ||
| PubChem | 154234 | ||
| Nikkaji | J1.350.588H | ||
| PDBe | BCZ | ||
| BindingDB | 5024 | 50181441 | |
| DrugCentral | 4823 | ||
| ChemicalBook | CB7970647 | ||
| rxnorm | PERAMIVIR | RAPIVAB | PERAMIVIR ANHYDROUS |
| PubChem: Drugs of the Future | 12015288 | ||
| ChEBI | 85202 | ||
| ZINC | ZINC000003981610 |
